D.A. Davidson & Co’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,792
Closed -$368K 1424
2022
Q4
$368K Sell
1,792
-232
-11% -$58.7K ﹤0.01% 957
2022
Q3
$563K Buy
2,024
+649
+47% +$165K 0.01% 777
2022
Q2
$263K Hold
1,375
﹤0.01% 1071
2022
Q1
$285K Sell
1,375
-300
-18% -$49.5K ﹤0.01% 1094
2021
Q4
$299K Hold
1,675
﹤0.01% 1059
2021
Q3
$345K Sell
1,675
-50
-3% -$9.82K ﹤0.01% 958
2021
Q2
$327K Sell
1,725
-240
-12% -$39.3K ﹤0.01% 958
2021
Q1
$256K Sell
1,965
-200
-9% -$24K ﹤0.01% 1013
2020
Q4
$225K Buy
+2,165
New +$188K ﹤0.01% 942

Other funds holding SWAV

D.A. Davidson & Co's SWAV Position: Q1 2023 in Review

D.A. Davidson & Co sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2023, closing a stake of 1,792 shares — an estimated $368K sold.

D.A. Davidson & Co first reported a position in SWAV in Q4 2020 and held it in 9 quarters. The position peaked at $563K in Q3 2022. 381 funds tracked by Wall St. Rank hold SWAV as of Q1 2023.

  • D.A. Davidson & Co reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • D.A. Davidson & Co sold 1,792 Shockwave Medical, Inc. Common Stock shares in Q1 2023, an estimated $368K.
  • D.A. Davidson & Co first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2020 and held it in 9 quarters.
  • D.A. Davidson & Co's Shockwave Medical, Inc. Common Stock position peaked at $563K in Q3 2022.
  • 381 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2023.

Based on D.A. Davidson & Co's 13F filing for Q1 2023, filed 25 Apr 2023.